Quantbot Technologies LP Amarin Corp Plcuk Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$1.09 - $1.67 $19,075 - $29,225	17,500 Added 52.08%	51,100 $55,000
Q2 2022 Aug 09, 2022	BUY	$1.13 - $3.69 $27,232 - $88,929	24,100 Added 253.68%	33,600 $50,000
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $27,075 - $35,435	9,500 New	9,500 $31,000
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $13,744 - $29,301	-3,776 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $18,049 - $31,189	3,776 New	3,776 $26,000
Q4 2019 Feb 10, 2020	SELL	$13.94 - $24.12 $57,154 - $98,892	-4,100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$13.89 - $23.16 $54,171 - $90,324	3,900 Added 1950.0%	4,100 $62,000
Q2 2019 Aug 13, 2019	BUY	$16.27 - $20.51 $3,254 - $4,102	200 New	200 $3,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.